Grzegorz S. Nowakowski

Author

Also Known As

G Nowakowski, G S Nowakowski, G. Nowakowski, G. S . Nowakowski, G. S Nowakowski, G. S. Nowakowski, G.S. Nowakowski, GRZEGORZ NOWAKOWSKI, Grzegorz (Greg) Nowakowski, Grzegorz Nowakowski

736

Publications

13.3K

Citations

H-Index

125

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Mayo Clinic in Florida WinnMed University of Iowa

About

Grzegorz S. Nowakowski is an author at Mayo Clinic in Arizona specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	55	2.9K
2	Health Sciences	11	12	543
3	Education	1	1	228
4	Engineering	1	1	11
5	Nursing	1	1	84

Grzegorz S. Nowakowski

163

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL Wei Ding, Betsy LaPlant, Timothy G. Call, Blood	2017	411
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma John P. Leonard, Marek Trněný, Koji Izutsu, Journal of Clinical Oncology	2019	401
Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Journal of Clinical Oncology	2014	362
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource Brian K. Link, Matthew J. Maurer, Grzegorz S. Nowakowski, Journal of Clinical Oncology	2013	326
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma Grzegorz S. Nowakowski, Annalisa Chiappella, Randy D. Gascoyne, Journal of Clinical Oncology	2021	252
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma Grzegorz S. Nowakowski, Thomas E. Witzig, David Dingli, Blood	2005	244
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology David W. Scott, Rebecca L. King, Annette M. Staiger, Blood	2018	236
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement Randall A. Oyer, Patricia A. Hurley, Leigh Boehmer, Journal of Clinical Oncology EthnicityConcerted CommitmentHealth Care DisparityCancer ManagementAmerican Society	2022	228
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma Matthew J. Maurer, Emmanuel Bachy, Hervé Ghesquières, American Journal of Hematology Lymphoid NeoplasiaCancer EpidemiologyMedicineEpidemiology Of CancerClinical Epidemiology	2016	219
Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma Matthew T. Drake, Matthew J. Maurer, Brian K. Link, Journal of Clinical Oncology	2010	205

Page 1